Skip to main content
Clinical Trials/NL-OMON48736
NL-OMON48736
Not yet recruiting
Not Applicable

Injection of Autologous Stromal Vascular Fraction enriched lipoaspirate for the treatment of vulvar Lichen Sclerosus - a pilot study - Injection of aSVF enriched lipoaspirate for vulvar Lichen Sclerosus

niversitair Medisch Centrum Groningen0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
15
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Postmenopausal women up to 80 years with ASA Physical Status Classification 0\-1
  • \- Histopathological confirmed diagnosis of lichen sclerosus
  • \- Moderate or severe lichen sclerosus (IGA scale 3 or 4\), therapy resistant to conventional therapy with highly potent topical steroids (insufficient reduction in clinical symptoms and signs having used topical steroids for 6 months).

Exclusion Criteria

  • \- Women with history of vulvar cancer or vulva intraepitheliale neoplasie (VIN) in addition to lichen sclerosus
  • \- An oncological event in the patient\*s history \< 5 years ago.
  • \- A known systemic disease that will impair wound healing (e.g. diabetes mellitus type I, known atherosclerosis with an event that required hospitalization, collagen diseases, diseases of the skin, HIV).
  • \- Systematic use of prednisone or other immunotherapy
  • \- Use of anticoagulant therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials